Concepedia

Daniel E. Meyers

DE

18

Publications

667

Citations

15

H-Index

2013

Active since

Affiliations

University of Calgary(Current)

University of Alberta

University of British Columbia

University of California, San Francisco

Queen's University

Daniel E. Meyers is an author at University of Calgary specializing in medicine, immunotherapy, and immunology.

ORCID

Top concepts

Publications per year

2013–2024

18

Publications

18

Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors

Sarah Cook, Vanessa Samuel, Daniel E. Meyers et al. · JAMA Network Open · 2024 · 121 citations · Full text

The Lung Immune Prognostic Index Discriminates Survival Outcomes in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors

Daniel E. Meyers, Igor Stukalin, Isabelle A. Vallerand et al. · Cancers · 2019 · 75 citations · Full text

Oncolytic Reovirus and Immune Checkpoint Inhibition as a Novel Immunotherapeutic Strategy for Breast Cancer

Ahmed Mostafa, Daniel E. Meyers, Chandini M. Thirukkumaran et al. · Cancers · 2018 · 61 citations · Full text

Association of Immune-Related Adverse Events, Hospitalization, and Therapy Resumption With Survival Among Patients With Metastatic Melanoma Receiving Single-Agent or Combination Immunotherapy

Alexander Watson, Siddhartha Goutam, Igor Stukalin et al. · JAMA Network Open · 2022 · 58 citations · Full text

Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials

Chun Loo Gan, Igor Stukalin, Daniel E. Meyers et al. · European Journal of Cancer · 2021 · 46 citations · Full text

Rows per page

1–5 of 18